Biomarkers for Oncology
JH · Effective Oct 1, 2015
52 active Medicare policies list 81292, and 6 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
J9 · Effective Oct 1, 2015
J9 · Effective Jul 17, 2023
JH · Effective Jul 17, 2023
JL · Effective Jul 17, 2023
J15 · Effective Aug 21, 2022
6 policies from 5 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of 81292 |
|---|---|---|
| Expanded Molecular Testing of Cancers to Select Targeted Therapies | Jul 1, 2026 | Covered |
| Genetic Testing for Lynch Syndrome and APC-associated and MUTYH-associated Polyposis Syndromes | Feb 1, 2026 | Covered |
| Policy | Effective | Status of 81292 |
|---|---|---|
| Tumor Markers | Mar 5, 2024 | Covered |
| Policy | Effective | Status of 81292 |
|---|---|---|
JE · Effective Aug 8, 2022
JF · Effective Aug 8, 2022
JJ · Effective Jul 3, 2022
JM · Effective Jul 3, 2022
J5 · Effective Jul 3, 2022
J8 · Effective Jul 3, 2022
J15 · Effective Oct 1, 2015
JE · Effective Oct 1, 2015
JF · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J5 · Effective Feb 16, 2017
J8 · Effective Feb 16, 2017
J15 · Effective Jun 7, 2020
JE · Effective Aug 3, 2020
JF · Effective Aug 3, 2020
JJ · Effective May 31, 2020
JM · Effective May 31, 2020
J5 · Effective Jun 14, 2020
J8 · Effective Jun 14, 2020
J9 · Effective Oct 1, 2015
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
JL · Effective Apr 24, 2025
J9 · Effective Oct 1, 2025
National · Effective Jan 1, 2026
National · Effective Feb 5, 2026
National · Effective Oct 1, 2025
J5 · Effective Jan 1, 2026
National · Effective Jan 1, 2026
National · Effective Jan 1, 2026
National · Effective Feb 5, 2026
J5 · Effective Apr 1, 2026
J5 · Effective Apr 1, 2026
National · Effective Jan 1, 2026
National · Effective Feb 5, 2026
National · Effective Jan 1, 2026
JL · Effective Apr 1, 2026
J9 · Effective Apr 1, 2026
J6 · Effective Feb 12, 2026
J9 · Effective Jan 1, 2024
| Concert Genetic Testing: Hereditary Cancer |
|---|
| Not recorded |
| Referenced |
| Policy | Effective | Status of 81292 |
|---|---|---|
| Hereditary Cancer Testing | Not recorded | Covered |
| Policy | Effective | Status of 81292 |
|---|---|---|
| Cigna Comprehensive Code List - Effective 03/07/2026 | Mar 7, 2026 | Prior auth required |